Home > About CIMERC
image of globe and cimerc logo

About CIMERC

The National Bioterrorism Civilian Medical Response Center (CIMERC) is a university-based, pre-planning organization designated by Congress in 2000 to develop innovative technologies for emergency medical response, including biological mass casualty preparedness.

CIMERC strives to develop tools that produce an effective integrated response to complex medical emergencies through research and collaborative relationships with universities, industry and government agencies. Recognizing the important differences between rural and urban response, CIMERC partnered with the Center of Excellence for Remote and Medically Under-Served Areas (CERMUSA). The strategic location of CIMERC at Drexel University in Philadelphia, PA, and CERMUSA at Saint Francis University in Loretto, PA provides immediate access to a diverse community of first responders.

With the support of these communities, CIMERC develops products that will assist the response community before, after and during a complex medical emergency. Each project falls into one of the following four categories:

CIMERC continues to demonstrate leadership in technology-oriented fields such as sensor development, imaging, multiple source communications networks, and microbial decontamination. Within the given concentration areas, CIMERC will continue to recognize and address the distinctive challenges presented by the urban and rural population centers in developing a cohesive response to complex medical emergencies, and will integrate ongoing efforts at regional, national and international levels.

The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. This investigation was funded under a U.S. Army Medical Research Acquisition Activity; Cooperative Agreement W81XWH 04-1-0419. The content of the information herein does not necessarily reflect the position or the policy of the U.S. Government or the U.S. Army and no official endorsement should be inferred.